$VECO
VEECO INSTRUMENTS INC Stock $veco

$veco Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000155837022001461 Filed on February 18, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$153.0M	$583.3M	$138.9M
YoY Change	10.09%	28.43%	22.74%
Cost Of Revenue	$88.95M	$341.0M	$82.10M
YoY Change	8.34%	31.22%	20.38%
Gross Profit	$64.02M	$242.3M	$56.85M
YoY Change	12.63%	24.69%	26.41%
Gross Profit Margin	41.85%	41.54%	40.91%
Selling, General & Admin	$21.21M	$84.54M	$20.70M
YoY Change	2.47%	10.87%	8.38%
% of Gross Profit	33.13%	34.89%	36.41%
Research & Development	$22.28M	$88.68M	$21.40M
YoY Change	4.13%	12.26%	-1.38%
% of Gross Profit	34.8%	36.6%	37.65%
Depreciation & Amortization	$6.424M	$26.06M	$7.700M
YoY Change	-16.57%	-15.11%	-10.47%
% of Gross Profit	10.03%	10.76%	13.55%
Operating Expenses	$46.40M	$185.6M	$46.20M
YoY Change	0.43%	8.05%	1.76%
Operating Profit	$17.62M	$56.71M	$10.65M
YoY Change	65.57%	151.32%	-2575.58%
Interest Expense	-$5.799M	$28.36M	-$6.500M
YoY Change	-10.78%	14.64%	38.3%
% of Operating Profit	-32.9%	50.01%	-61.06%
Other Income/Expense, Net	-$5.010M	-$5.010M
YoY Change		-36.11%
Pretax Income	$6.816M	$25.68M	-$700.0K
YoY Change	-1073.71%	-403.4%	-97.85%
Income Tax	-$1.387M	-$358.0K	-$600.0K
% Of Pretax Income	-20.35%	-1.39%
Net Earnings	$8.203M	$26.04M	-$102.0K
YoY Change	-8142.16%	-410.31%	-99.69%
Net Earnings / Revenue	5.36%	4.46%	-0.07%
Basic Earnings Per Share		$0.53	$0.00
Diluted Earnings Per Share	$152.6K	$0.49	$0.00
COMMON SHARES
Basic Shares Outstanding	50.50M	49.07M	49.61M
Diluted Shares Outstanding		53.64M

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$223.9M	$223.9M	$319.4M
YoY Change	-29.89%	-29.89%	30.61%
Cash & Equivalents	$119.7M	$119.7M	$129.6M
Short-Term Investments	$104.2M	$104.2M	$189.8M
Other Short-Term Assets	$26.70M	$26.70M	$20.40M
YoY Change	30.88%	30.88%	-25.27%
Inventory	$170.9M	$170.9M	$145.9M
Prepaid Expenses
Receivables	$109.6M	$127.9M	$79.99M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$549.4M	$549.4M	$586.9M
YoY Change	-6.4%	-6.39%	23.34%
LONG-TERM ASSETS
Property, Plant & Equipment	$99.74M	$128.6M	$65.27M
YoY Change	52.81%	70.27%	-13.79%
Goodwill	$181.9M		$181.9M
YoY Change	0.0%		0.0%
Intangibles	$33.91M		$46.19M
YoY Change	-26.59%		-24.92%
Long-Term Investments
YoY Change
Other Assets	$3.546M	$5.185M	$6.019M
YoY Change	-41.09%	-30.87%	-14.45%
Total Long-Term Assets	$349.6M	$349.6M	$311.1M
YoY Change	12.36%	12.34%	-9.08%
TOTAL ASSETS
Total Short-Term Assets	$549.4M	$549.4M	$586.9M
Total Long-Term Assets	$349.6M	$349.6M	$311.1M
Total Assets	$899.0M	$899.0M	$898.1M
YoY Change	0.1%	0.1%	9.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$44.46M	$44.46M	$33.66M
YoY Change	32.09%	31.92%	58.15%
Accrued Expenses	$79.75M	$79.75M	$44.90M
YoY Change	77.62%	77.62%	8.98%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$189.2M	$189.2M	$146.7M
YoY Change	28.99%	28.97%	24.07%
LONG-TERM LIABILITIES
Long-Term Debt	$229.4M	$229.4M	$321.1M
YoY Change	-28.55%	-28.55%	7.01%
Other Long-Term Liabilities	$5.080M	$37.91M	$10.35M
YoY Change	-50.91%	127.03%	10.85%
Total Long-Term Liabilities	$234.5M	$267.4M	$331.5M
YoY Change	-29.25%	-20.85%	7.13%
TOTAL LIABILITIES
Total Short-Term Liabilities	$189.2M	$189.2M	$146.7M
Total Long-Term Liabilities	$234.5M	$267.4M	$331.5M
Total Liabilities	$461.3M	$461.3M	$489.7M
YoY Change	-5.79%	-5.79%	10.4%
SHAREHOLDERS EQUITY
Retained Earnings	-$681.3M		-$707.3M
YoY Change	-3.68%		1.2%
Common Stock	$1.117B		$1.114B
YoY Change	0.32%		3.95%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$437.6M	$437.6M	$408.4M
YoY Change
Total Liabilities & Shareholders Equity	$899.0M	$899.0M	$898.1M
YoY Change	0.1%	0.1%	9.78%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	$8.203M	$26.04M	-$102.0K
YoY Change	-8142.16%	-410.31%	-99.69%
Depreciation, Depletion And Amortization	$6.424M	$26.06M	$7.700M
YoY Change	-16.57%	-15.11%	-10.47%
Cash From Operating Activities	$17.09M	$67.74M	$15.40M
YoY Change	10.99%	57.46%	-1.28%
INVESTING ACTIVITIES
Capital Expenditures	-$9.190M	$40.64M	-$3.500M
YoY Change	162.57%	497.52%	29.63%
Acquisitions
YoY Change
Other Investing Activities	$110.8M	$85.17M	-$28.50M
YoY Change	-488.8%	-231.03%	48.44%
Cash From Investing Activities	$101.6M	$44.53M	-$31.90M
YoY Change	-418.55%	-162.02%	45.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-120.5M	-122.0M	-1.500M
YoY Change	7931.87%	-519.37%	-600.0%
NET CHANGE
Cash From Operating Activities	17.09M	67.74M	15.40M
Cash From Investing Activities	101.6M	44.53M	-31.90M
Cash From Financing Activities	-120.5M	-122.0M	-1.500M
Net Change In Cash	-1.767M	-9.811M	-18.00M
YoY Change	-90.18%	-3055.12%	200.0%
FREE CASH FLOW
Cash From Operating Activities	$17.09M	$67.74M	$15.40M
Capital Expenditures	-$9.190M	$40.64M	-$3.500M
Free Cash Flow	$26.28M	$27.10M	$18.90M
YoY Change	39.06%	-25.18%	3.28%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	26038000
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-8391000
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-78733000
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021	veco	Irrevocable Letters Of Credit Maturity Period Minimum IrrevocableLettersOfCreditMaturityPeriodMinimum	P0D
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	50652864
CY2021	veco	Number Of Trading Days Considered To Calculate Market Capitalization NumberOfTradingDaysConsideredToCalculateMarketCapitalization	P10D
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49723751
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.veeco.com/20211231#AccruedAndOtherLiabilitiesCurrent
CY2021Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OperatingLeaseLiabilityNoncurrent http://www.veeco.com/20211231#AccruedAndOtherLiabilitiesCurrent
CY2020Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.veeco.com/20211231#AccruedAndOtherLiabilitiesCurrent
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.veeco.com/20211231#AccruedAndOtherLiabilitiesCurrent
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0000103145
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2017Q1	us-gaap	Long Term Debt Measurement Input Extensible List LongTermDebtMeasurementInputExtensibleList	http://fasb.org/us-gaap/2021-01-31#MeasurementInputDiscountRateMember
CY2020Q4	us-gaap	Long Term Debt Measurement Input Extensible List LongTermDebtMeasurementInputExtensibleList	http://fasb.org/us-gaap/2021-01-31#MeasurementInputDiscountRateMember
CY2020Q2	us-gaap	Long Term Debt Measurement Input Extensible List LongTermDebtMeasurementInputExtensibleList	http://fasb.org/us-gaap/2021-01-31#MeasurementInputDiscountRateMember
CY2021Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	443000
CY2021	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P1Y
CY2021	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P1Y
CY2021Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	32.15
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3546000
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6019000
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P2Y
CY2021	dei	Document Type DocumentType	10-K
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	25628000
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	0-16244
CY2021	dei	Entity Registrant Name EntityRegistrantName	VEECO INSTRUMENTS INC
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	11-2989601
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	Terminal Drive
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Plainview
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	11803
CY2021	dei	City Area Code CityAreaCode	516
CY2021	dei	Local Phone Number LocalPhoneNumber	677-0200
CY2021	dei	Security12b Title Security12bTitle	Common Stock
CY2021	dei	Trading Symbol TradingSymbol	VECO
CY2021	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	false
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2021Q3	dei	Entity Public Float EntityPublicFloat	1150234164
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	50653403
CY2021	dei	Auditor Firm AuditorFirmId	185
CY2021	dei	Auditor Name AuditorName	KPMG LLP
CY2021	dei	Auditor Location AuditorLocation	Melville, New York
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	119747000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	129625000
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	725000
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	658000
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	104181000
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	189771000
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	109609000
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	79991000
CY2021Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	18293000
CY2020Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	21246000
CY2021Q4	us-gaap	Inventory Net InventoryNet	170858000
CY2020Q4	us-gaap	Inventory Net InventoryNet	145906000
CY2021Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	346000
CY2020Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	433000
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	19301000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	549387000
CY2020Q4	us-gaap	Assets Current AssetsCurrent	586931000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	99743000
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	65271000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-681283000
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	1551000
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1440000
CY2019	us-gaap	Investment Income Interest InvestmentIncomeInterest	4680000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	28813000
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10275000
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	33905000
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	46185000
CY2021Q4	us-gaap	Goodwill Goodwill	181943000
CY2020Q4	us-gaap	Goodwill Goodwill	181943000
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1639000
CY2021Q4	us-gaap	Assets Assets	898976000
CY2020Q4	us-gaap	Assets Assets	898064000
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	44456000
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	33656000
CY2021Q4	veco	Accrued And Other Liabilities Current AccruedAndOtherLiabilitiesCurrent	79752000
CY2020Q4	veco	Accrued And Other Liabilities Current AccruedAndOtherLiabilitiesCurrent	44876000
CY2021Q4	veco	Contract With Customer Liability And Refund Liability Current ContractWithCustomerLiabilityAndRefundLiabilityCurrent	63136000
CY2020Q4	veco	Contract With Customer Liability And Refund Liability Current ContractWithCustomerLiabilityAndRefundLiabilityCurrent	67235000
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1860000
CY2020Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	914000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	189204000
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	146681000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	4792000
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	5240000
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	229438000
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	321115000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	32834000
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6305000
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5080000
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	10349000
CY2021Q4	us-gaap	Liabilities Liabilities	461348000
CY2020Q4	us-gaap	Liabilities Liabilities	489690000
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	120000000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	120000000
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50652864
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49723751
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	507000
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	497000
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1116921000
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1113352000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8464000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-77956000
CY2021	us-gaap	Interest Expense InterestExpense	28360000
CY2020	us-gaap	Interest Expense InterestExpense	24739000
CY2019	us-gaap	Interest Expense InterestExpense	22085000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5010000
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-7841000
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-20973000
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-707321000
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1483000
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1846000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	437628000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	408374000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	898976000
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	898064000
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	583277000
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	454163000
CY2019	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	419349000
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	341003000
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	259863000
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	261155000
CY2021	us-gaap	Gross Profit GrossProfit	242274000
CY2020	us-gaap	Gross Profit GrossProfit	194300000
CY2019	us-gaap	Gross Profit GrossProfit	158194000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	88680000
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	78994000
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	90557000
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	84536000
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	76251000
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	79749000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	12280000
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	15333000
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	17085000
CY2020	us-gaap	Restructuring Charges RestructuringCharges	1097000
CY2019	us-gaap	Restructuring Charges RestructuringCharges	6403000
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	281000
CY2019	us-gaap	Asset Impairment Charges AssetImpairmentCharges	4020000
CY2021	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-68000
CY2020	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	221000
CY2019	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	42000
CY2021	us-gaap	Operating Expenses OperatingExpenses	185564000
CY2020	us-gaap	Operating Expenses OperatingExpenses	171735000
CY2019	us-gaap	Operating Expenses OperatingExpenses	197772000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	56710000
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	22565000
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-39578000
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	2340000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	25680000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-358000
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.66
CY2020	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	556000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-73000
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	777000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	26038000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-8391000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-78733000
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.53
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.66
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.49
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49073000
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48362000
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47482000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53643000
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48362000
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47482000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	26038000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-8391000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-78733000
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-311000
CY2020	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-53000
CY2019	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	49000
CY2021	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-311000
CY2020	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-53000
CY2019	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	49000
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-52000
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	5000
CY2019	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-19000
CY2019	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	-44000
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-52000
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	5000
CY2019	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	25000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-363000
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-48000
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	74000
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	25675000
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8439000
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-78659000
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	437775000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-78733000
CY2019	veco	Other Comprehensive Income Loss Including Foreign Currency Gains Losses On Transactions Included In Operating Results Net Of Tax OtherComprehensiveIncomeLossIncludingForeignCurrencyGainsLossesOnTransactionsIncludedInOperatingResultsNetOfTax	74000
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	15270000
CY2019	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	126000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	374512000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-8391000
CY2020	veco	Other Comprehensive Income Loss Including Foreign Currency Gains Losses On Transactions Included In Operating Results Net Of Tax OtherComprehensiveIncomeLossIncludingForeignCurrencyGainsLossesOnTransactionsIncludedInOperatingResultsNetOfTax	-48000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	12703000
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.53
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	9096000
CY2021	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	947000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	408374000
CY2020	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	86000
CY2019	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	-655000
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	687000
CY2020	veco	Adjustments To Additional Paid In Capital Extinguishment Equity Component Of Notes Repurchased AdjustmentsToAdditionalPaidInCapitalExtinguishmentEquityComponentOfNotesRepurchased	14714000
CY2020	veco	Adjustments To Additional Paid In Capital Purchase Of Derivative Instrument AdjustmentsToAdditionalPaidInCapitalPurchaseOfDerivativeInstrument	10313000
CY2019	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-408000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	26038000
CY2021	veco	Other Comprehensive Income Loss Including Foreign Currency Gains Losses On Transactions Included In Operating Results Net Of Tax OtherComprehensiveIncomeLossIncludingForeignCurrencyGainsLossesOnTransactionsIncludedInOperatingResultsNetOfTax	-363000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	15249000
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-5590000
CY2021	veco	Adjustments To Additional Paid In Capital Extinguishment Equity Component Of Notes Repurchased AdjustmentsToAdditionalPaidInCapitalExtinguishmentEquityComponentOfNotesRepurchased	6080000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	437628000
CY2021	us-gaap	Profit Loss ProfitLoss	26038000
CY2020	us-gaap	Profit Loss ProfitLoss	-8391000
CY2019	us-gaap	Profit Loss ProfitLoss	-78733000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	26058000
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	30697000
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	34399000
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	13819000
CY2020	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	13792000
CY2019	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	12676000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-651000
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-299000
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	360000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	15249000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	12703000
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	15270000
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-4029000
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-7841000
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	281000
CY2019	us-gaap	Asset Impairment Charges AssetImpairmentCharges	4020000
CY2021	us-gaap	Impairment Of Investments ImpairmentOfInvestments	980000
CY2019	us-gaap	Impairment Of Investments ImpairmentOfInvestments	20973000
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	140000
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	392000
CY2021	veco	Increase Decrease In Accounts Receivable And Contract Assets IncreaseDecreaseInAccountsReceivableAndContractAssets	26664000
CY2020	veco	Increase Decrease In Accounts Receivable And Contract Assets IncreaseDecreaseInAccountsReceivableAndContractAssets	30361000
CY2019	veco	Increase Decrease In Accounts Receivable And Contract Assets IncreaseDecreaseInAccountsReceivableAndContractAssets	-5796000
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	24803000
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	11528000
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-14969000
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-7621000
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2610000
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-7520000
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	20225000
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	15959000
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-26945000
CY2021	veco	Increase Decrease In Customer Deposits And Deferred Revenue IncreaseDecreaseInCustomerDepositsAndDeferredRevenue	-4099000
CY2020	veco	Increase Decrease In Customer Deposits And Deferred Revenue IncreaseDecreaseInCustomerDepositsAndDeferredRevenue	12424000
CY2019	veco	Increase Decrease In Customer Deposits And Deferred Revenue IncreaseDecreaseInCustomerDepositsAndDeferredRevenue	-17866000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	67742000
CY2021	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-8993000
CY2020	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-2287000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	43021000
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7416000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	40643000
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6802000
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10873000
CY2021	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	330702000
CY2020	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	173530000
CY2019	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	127349000
CY2021	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	247256000
CY2020	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	248023000
CY2019	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	192988000
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1725000
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	9503000
CY2019	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	645000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	44528000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-71792000
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-75867000
CY2020	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	120095000
CY2020	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	10313000
CY2021	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	115604000
CY2020	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	81240000
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	835000
CY2021	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	3402000
CY2020	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	2878000
CY2019	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	3106000
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	8992000
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2322000
CY2019	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2980000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-122029000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	29098000
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	126000
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-52000
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5000
CY2019	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	26000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-9811000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	332000
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-83131000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	130283000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	129951000
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	213082000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	120472000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	130283000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	129951000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	12551000
CY2019	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	249000
CY2021Q4	veco	Share Based Compensation Arrangement By Share Based Payment Award Service Conditions And Graded Vesting Number Of Awards ShareBasedCompensationArrangementByShareBasedPaymentAwardServiceConditionsAndGradedVestingNumberOfAwards	1
CY2020Q4	veco	Trade Receivables Under Receivable Purchase Agreement Outstanding TradeReceivablesUnderReceivablePurchaseAgreementOutstanding	5900000
CY2021Q4	veco	Receivable Purchase Agreement Amount Available ReceivablePurchaseAgreementAmountAvailable	15000000.0
CY2021Q4	us-gaap	Deposit Assets DepositAssets	3900000
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	329000
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2931000
CY2020	us-gaap	Interest Paid Net InterestPaidNet	12700000
CY2019	us-gaap	Interest Paid Net InterestPaidNet	9408000
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-139000
CY2021	veco	Transfer To Inventories TransferToInventories	63000
CY2020	veco	Transfer To Inventories TransferToInventories	1624000
CY2019	veco	Transfer To Inventories TransferToInventories	-4916000
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	23777000
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1741000
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	5576000
CY2021	us-gaap	Fiscal Period FiscalPeriod	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">(b) Basis of Presentation</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><span style="font-size:10pt;">The accompanying audited Consolidated Financial Statements of the Company have been prepared in accordance with United States generally accepted accounting principles (“GAAP”). The Company reports interim quarters on a </span><span style="font-size:10pt;">13</span><span style="font-size:10pt;">-week basis ending on the last Sunday of each period, which is determined at the start of each year. The Company’s fourth quarter always ends on the last day of the calendar year, December 31. During 2021 the interim quarters ended on April 4, July 4, and October 3, and during 2020 the interim quarters ended on March 29, June 28, and September 27. The Company reports these interim quarters as March 31, June 30, and September 30 in its interim consolidated financial statements.</span></p>
CY2021Q1	us-gaap	Fiscal Period Duration FiscalPeriodDuration	P91D
CY2021Q2	us-gaap	Fiscal Period Duration FiscalPeriodDuration	P91D
CY2021Q3	us-gaap	Fiscal Period Duration FiscalPeriodDuration	P91D
CY2021Q4	us-gaap	Fiscal Period Duration FiscalPeriodDuration	P91D
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">(c) Use of Estimates</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Although these estimates are based on management’s knowledge of current events and actions it may undertake in the future, these estimates may ultimately differ from actual results. Significant items subject to such estimates and assumptions include: (i) stand-alone selling prices for the Company’s products and services; (ii) allowances for doubtful accounts; (iii) inventory obsolescence; (iv) the useful lives and expected future cash flows of property, plant, and equipment and identifiable intangible assets; (v) the fair value of the Company’s reporting unit and related goodwill; (vi) investment valuations and the valuation of derivatives, deferred tax assets, and assets acquired in business combinations; (vii) the recoverability of long-lived assets; (viii) liabilities for product warranty and legal contingencies; (ix) share-based compensation; (x) lease term and incremental borrowing rates used in determining operating lease assets and liabilities; and (xi) income tax uncertainties.</p>
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.66
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.49
CY2021	us-gaap	Revenue Practical Expedient Incremental Cost Of Obtaining Contract RevenuePracticalExpedientIncrementalCostOfObtainingContract	true
CY2021	veco	Product Warranty Period ProductWarrantyPeriod	P1Y
CY2021	us-gaap	Advertising Expense AdvertisingExpense	300000
CY2020	us-gaap	Advertising Expense AdvertisingExpense	400000
CY2019	us-gaap	Advertising Expense AdvertisingExpense	500000
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	26038000
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">(l) Concentration of Credit Risk</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, investments, derivative financial instruments used in hedging activities, and accounts receivable. The Company invests in a variety of financial instruments and, by policy, limits the amount of credit exposure with any one financial institution or commercial issuer. Historically, the Company has not experienced any material credit losses on its investments. </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Company maintains an allowance reserve for potentially uncollectible accounts for estimated losses resulting from the inability of its customers to make required payments. The Company evaluates its allowance for doubtful accounts based on a combination of factors. In circumstances where specific invoices are deemed to be uncollectible, the Company provides a specific allowance for bad debt against the amount due to reduce the net recognized receivable to the amount reasonably expected to be collected. The Company also provides allowances based on its write-off history. Finally, the Company also considers its current expectations of future economic conditions, including the impact of COVID-19, when estimating its allowance for doubtful accounts. The allowance for doubtful accounts totaled $0.7 million at both December 31, 2021 and 2020.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><span style="font-size:10pt;">To further mitigate the Company’s exposure to uncollectable accounts, the Company may request certain customers provide a negotiable irrevocable letter of credit drawn on a reputable financial institution. These irrevocable letters of credit are typically issued to mature between </span><span style="-sec-ix-hidden:Hidden_lLLL67cC-kS_kJateyYGvg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">zero</span></span><span style="font-size:10pt;"> and </span><span style="font-size:10pt;">90 days</span><span style="font-size:10pt;"> from the date the documentation requirements are met, typically when a system ships or upon receipt of final acceptance from the customer. The Company, at its discretion, may monetize these letters of credit on a non-recourse basis after they become negotiable but before maturity. The fees associated with the monetization are included in “Selling, general, and administrative” in the Consolidated Statements of Operations and were immaterial for the years ended December 31, 2021, 2020, and 2019.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;"></span></p>
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	700000
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	700000
CY2021	veco	Irrevocable Letters Of Credit Maturity Period Maximum IrrevocableLettersOfCreditMaturityPeriodMaximum	P90D
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	41700000
CY2020Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	86200000
CY2021Q4	veco	Cash And Cash Equivalents Maintained Outside By Subsidiaries As Percent CashAndCashEquivalentsMaintainedOutsideBySubsidiariesAsPercent	0.32
CY2020Q4	veco	Cash And Cash Equivalents Maintained Outside By Subsidiaries As Percent CashAndCashEquivalentsMaintainedOutsideBySubsidiariesAsPercent	0.31
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8391000
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-78733000
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48362000
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47482000
CY2020Q4	us-gaap	Interest Payable Current InterestPayableCurrent	2574000
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1467000
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.66
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49073000
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1090000
CY2021	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	3480000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53643000
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48362000
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47482000
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	104512000
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	331000
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	104181000
CY2020Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	189791000
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	15000
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	35000
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	189771000
CY2021Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	103182000
CY2021Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	331000
CY2020Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	52545000
CY2020Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	35000
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	0
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	0
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis	53617000
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	53550000
CY2021Q4	veco	Debt Securities Available For Sale Maturity Allocated And Single Maturity Date Rolling After One Through Two Years Amortized Cost DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterOneThroughTwoYearsAmortizedCost	50895000
CY2021Q4	veco	Debt Securities Available For Sale Maturity Allocated And Single Maturity Date Rolling After One Through Two Years Fair Value DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterOneThroughTwoYearsFairValue	50631000
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	104512000
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	104181000
CY2021Q4	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	15000000
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	96027000
CY2020Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	82679000
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	54128000
CY2020Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	53979000
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	20703000
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	9248000
CY2021Q4	us-gaap	Inventory Net InventoryNet	170858000
CY2020Q4	us-gaap	Inventory Net InventoryNet	145906000
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	260642000
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	215090000
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	160899000
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	149819000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	99743000
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	65271000
CY2021	us-gaap	Depreciation Depreciation	13800000
CY2020	us-gaap	Depreciation Depreciation	15400000
CY2019	us-gaap	Depreciation Depreciation	17300000
CY2019	us-gaap	Proceeds From Sale Of Land Held For Use ProceedsFromSaleOfLandHeldForUse	600000
CY2011	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	0
CY2020	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	0
CY2020Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1112000
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	4889000
CY2020Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	2658000
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	7612000
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P12Y
CY2019Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	7067000
CY2021Q4	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2021Q4	us-gaap	Goodwill Gross GoodwillGross	430331000
CY2021Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	248388000
CY2021Q4	us-gaap	Goodwill Goodwill	181943000
CY2021	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P5Y
CY2021Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	508969000
CY2021Q4	veco	Intangible Assets Excluding Goodwill Accumulated Amortization And Impairment IntangibleAssetsExcludingGoodwillAccumulatedAmortizationAndImpairment	475064000
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	33905000
CY2020Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	508969000
CY2020Q4	veco	Intangible Assets Excluding Goodwill Accumulated Amortization And Impairment IntangibleAssetsExcludingGoodwillAccumulatedAmortizationAndImpairment	462784000
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	46185000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	10018000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	8347000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	6708000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	3136000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	2134000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	3562000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	33905000
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	35712000
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	26630000
CY2021Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	7878000
CY2020Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	5058000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4437000
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4148000
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	2757000
CY2020Q4	us-gaap	Deposit Assets DepositAssets	7200000
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2696000
CY2021Q4	veco	Accrued And Other Liabilities Current AccruedAndOtherLiabilitiesCurrent	79752000
CY2020Q4	veco	Accrued And Other Liabilities Current AccruedAndOtherLiabilitiesCurrent	44876000
CY2021Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	46900000
CY2020Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	49300000
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	17985000
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-6782000
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-8491000
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	16276000
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	33600000
CY2021Q4	veco	Revenue Remaining Performance Obligation Expected Timing Percentage RevenueRemainingPerformanceObligationExpectedTimingPercentage	0.94
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2021	us-gaap	Revenue Practical Expedient Remaining Performance Obligation RevenuePracticalExpedientRemainingPerformanceObligation	true
CY2020Q4	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	3600000
CY2020Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	5058000
CY2019Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	7067000
CY2018Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	7852000
CY2021	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	7102000
CY2020	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	4626000
CY2019	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	5865000
CY2021	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	5784000
CY2020	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	6691000
CY2019	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	6242000
CY2021	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	1502000
CY2020	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	56000
CY2019	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	-408000
CY2021Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	7878000
CY2020Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	5058000
CY2021Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.057
CY2021Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Due In Next Rolling Twelve Months UnrecordedUnconditionalPurchaseObligationDueInNextRollingTwelveMonths	193000000.0
CY2021Q4	us-gaap	Guarantee Obligations Current Carrying Value GuaranteeObligationsCurrentCarryingValue	2700000
CY2021Q4	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	15200000
CY2020Q2	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	10300000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	4901000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	3979000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	3769000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	3309000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	3496000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	35960000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	55414000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	18143000
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	37271000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4437000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	32834000
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	37271000
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	6600000
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	5400000
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	5500000
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	1700000
CY2019	us-gaap	Variable Lease Cost VariableLeaseCost	1700000
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	1700000
CY2021	us-gaap	Lease Cost LeaseCost	8400000
CY2020	us-gaap	Lease Cost LeaseCost	7100000
CY2019	us-gaap	Lease Cost LeaseCost	7200000
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	6600000
CY2021	veco	Reimbursement For Leasehold Improvements ReimbursementForLeaseholdImprovements	6100000
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	6900000
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	7200000
CY2020Q4	veco	Receivable Purchase Agreement Maximum Amount ReceivablePurchaseAgreementMaximumAmount	15000000.0
CY2020	veco	Trade Receivables Sold Under Receivable Purchase Agreement TradeReceivablesSoldUnderReceivablePurchaseAgreement	11600000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	4587000
CY2021Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	9908000
CY2021Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	277673000
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	48235000
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	229438000
CY2020Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	389195000
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	68080000
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	321115000
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	26282000
CY2020	us-gaap	Interest Expense Debt InterestExpenseDebt	24640000
CY2019	us-gaap	Interest Expense Debt InterestExpenseDebt	21991000
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2017Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	100000000
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	14300000
CY2017Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	100000000
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	15249000
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12703000
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	15270000
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	24218000
CY2021	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y10M24D
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1222000
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	34.80
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	103000
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	33.97
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1119000
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	34.88
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	389000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	34.15
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	730000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	35.26
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2000
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	23.36
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	285000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	40.16
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	443000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	32.15
CY2021Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	443000
CY2021Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	32.15
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	0
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	37000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	6000
CY2021	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.50
CY2021	veco	Defined Contribution Plan Employer Matching Contribution Vesting Period DefinedContributionPlanEmployerMatchingContributionVestingPeriod	P5Y
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	2600000
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	2400000
CY2019	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	2400000
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	162000
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-507000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	23561000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-10292000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-78486000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	2119000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	1828000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	530000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	25680000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8464000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-77956000
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	183000
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	22000
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	304000
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	110000
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	204000
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	113000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	293000
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	226000
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	417000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	119000
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	136000
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	5880000
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-115000
CY2020Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	10982000
CY2021Q4	veco	Deferred Tax Assets Operating Leases DeferredTaxAssetsOperatingLeases	8464000
CY2020Q4	veco	Deferred Tax Assets Operating Leases DeferredTaxAssetsOperatingLeases	2281000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	54160000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	1730000
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-320000
CY2019	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	116000
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-263000
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	82000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-651000
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-299000
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	360000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-358000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-73000
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	777000
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	5393000
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1777000
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-16396000
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-607000
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-121000
CY2019	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-835000
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	609000
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-131000
CY2019	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	785000
CY2021	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	3964000
CY2020	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	-726000
CY2019	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	1692000
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-2389000
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	388000
CY2019	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	15098000
CY2021	veco	Income Tax Reconciliation Change In Accrual For Unrecognized Tax Benefits IncomeTaxReconciliationChangeInAccrualForUnrecognizedTaxBenefits	-398000
CY2020	veco	Income Tax Reconciliation Change In Accrual For Unrecognized Tax Benefits IncomeTaxReconciliationChangeInAccrualForUnrecognizedTaxBenefits	6000
CY2019	veco	Income Tax Reconciliation Change In Accrual For Unrecognized Tax Benefits IncomeTaxReconciliationChangeInAccrualForUnrecognizedTaxBenefits	-1232000
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	1208000
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	2248000
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	1947000
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	728000
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	495000
CY2021	veco	Effective Income Tax Rate Reconciliation Partial Extinguishment Of Debt Amount EffectiveIncomeTaxRateReconciliationPartialExtinguishmentOfDebtAmount	-1090000
CY2020	veco	Effective Income Tax Rate Reconciliation Partial Extinguishment Of Debt Amount EffectiveIncomeTaxRateReconciliationPartialExtinguishmentOfDebtAmount	-2292000
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	84000
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	164000
CY2019	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	143000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-358000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-73000
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	777000
CY2021Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	11822000
CY2020Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	10949000
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	38816000
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	51260000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	57810000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	1045000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	4033000
CY2021Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	400000
CY2021Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	400000
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	4741000
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	138463000
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	140005000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	116054000
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	118443000
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	22409000
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	21562000
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	6633000
CY2020Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	7227000
CY2021Q4	us-gaap	Deferred Tax Liabilities Financing Arrangements DeferredTaxLiabilitiesFinancingArrangements	10018000
CY2020Q4	us-gaap	Deferred Tax Liabilities Financing Arrangements DeferredTaxLiabilitiesFinancingArrangements	13674000
CY2021Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	6539000
CY2020Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	2241000
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	2372000
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	2220000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	25562000
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	25362000
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	3153000
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	3800000
CY2021Q4	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	800000
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-2400000
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	12363000
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	12369000
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	11137000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	2642000
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	1217000
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	3075000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	50000
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	47000
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	21000
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	1196000
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	1166000
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	1814000
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	1098000
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	104000
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	50000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	12761000
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	12363000
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	12369000
CY2020Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	400000
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	583277000
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	454163000
CY2019	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	419349000
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	583277000
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	454163000
CY2019	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	419349000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	99743000
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	65271000
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	75711000
CY2020Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	119179000
CY2021	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	2389000
CY2021Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	116790000
CY2019Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	130655000
CY2020	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	653000
CY2020	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	12129000
CY2020Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	119179000
CY2018Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	115225000
CY2019	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	15490000
CY2019	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	60000
CY2019Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	130655000

Files In Submission

Name	View Source	Status
0001558370-22-001461-index-headers.html	Edgar Link	pending
0001558370-22-001461-index.html	Edgar Link	pending
0001558370-22-001461.txt	Edgar Link	pending
0001558370-22-001461-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
veco-20211231.xsd	Edgar Link	pending
veco-20211231x10k.htm	Edgar Link	pending
veco-20211231x10k004.jpg	Edgar Link	pending
veco-20211231x10k005.jpg	Edgar Link	pending
veco-20211231x10k_htm.xml	Edgar Link	completed
veco-20211231xex21d1.htm	Edgar Link	pending
veco-20211231xex23d1.htm	Edgar Link	pending
veco-20211231xex31d1.htm	Edgar Link	pending
veco-20211231xex31d2.htm	Edgar Link	pending
veco-20211231xex32d1.htm	Edgar Link	pending
veco-20211231xex32d2.htm	Edgar Link	pending
veco-20211231_cal.xml	Edgar Link	unprocessable
veco-20211231_def.xml	Edgar Link	unprocessable
veco-20211231_lab.xml	Edgar Link	unprocessable
veco-20211231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VECO
VEECO INSTRUMENTS INC Stock $veco

2021 Q4 Form 10-K Financial Statement

#000155837022001461 Filed on February 18, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VECO VEECO INSTRUMENTS INC Stock $veco

2021 Q4 Form 10-K Financial Statement

#000155837022001461 Filed on February 18, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VECO
VEECO INSTRUMENTS INC Stock $veco